ExodusPoint Capital Management LP Acquires New Position in Astrana Health, Inc. (NASDAQ:ASTH)

ExodusPoint Capital Management LP acquired a new stake in Astrana Health, Inc. (NASDAQ:ASTH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 36,150 shares of the company’s stock, valued at approximately $1,140,000. ExodusPoint Capital Management LP owned 0.06% of Astrana Health as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Handelsbanken Fonder AB lifted its position in Astrana Health by 4.7% in the fourth quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock valued at $281,000 after purchasing an additional 400 shares during the period. Swiss National Bank lifted its position in shares of Astrana Health by 1.1% during the 4th quarter. Swiss National Bank now owns 88,444 shares of the company’s stock valued at $2,789,000 after acquiring an additional 1,000 shares during the period. Pictet Asset Management Holding SA boosted its stake in shares of Astrana Health by 21.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company’s stock worth $223,000 after acquiring an additional 1,273 shares in the last quarter. KBC Group NV boosted its stake in shares of Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after acquiring an additional 1,316 shares in the last quarter. Finally, Moran Wealth Management LLC boosted its stake in shares of Astrana Health by 21.5% during the 4th quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock worth $250,000 after acquiring an additional 1,404 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Truist Financial decreased their price target on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Robert W. Baird decreased their price target on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a research note on Monday, March 3rd. Barclays assumed coverage on Astrana Health in a research note on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price target on the stock. Macquarie raised Astrana Health to a “hold” rating in a research note on Monday, December 16th. Finally, Stifel Nicolaus decreased their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Astrana Health presently has an average rating of “Moderate Buy” and an average target price of $53.29.

Astrana Health Trading Up 2.7 %

Shares of ASTH opened at $31.93 on Thursday. The stock has a fifty day moving average of $32.55 and a two-hundred day moving average of $40.35. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The company has a market capitalization of $1.60 billion, a PE ratio of 24.56, a price-to-earnings-growth ratio of 1.37 and a beta of 1.04. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.